Related Experiment Video
Updated: Feb 7, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Pulmonary arteriovenous malformations: endovascular therapy
Murthy R Chamarthy1, Harold Park1, Patrick Sutphin1
1Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pulmonary arteriovenous malformations (PAVMs) are abnormal vessel connections often seen in hereditary hemorrhagic telangiectasia (HHT). Endovascular therapy offers a minimally invasive treatment option for PAVMs, effectively closing abnormal shunts with minimal risk.
Area of Science:
- Vascular Medicine
- Interventional Radiology
- Cardiopulmonary Medicine
Background:
- Pulmonary arteriovenous malformations (PAVMs) are direct abnormal connections between pulmonary arteries and veins.
- PAVMs are frequently associated with hereditary hemorrhagic telangiectasia (HHT).
- Untreated PAVMs can lead to hypoxemia, stroke, and intracranial abscess due to right-to-left shunting.
Purpose of the Study:
- To review the indications and contraindications for endovascular therapy in PAVMs.
- To detail the pre-procedural workup, procedural techniques, and variations.
- To discuss potential complications and outcomes associated with endovascular treatment of PAVMs.
Main Methods:
- Endovascular therapy involves occluding the feeding artery of the PAVM using coils, plugs, or a combination.
- This minimally invasive procedure is typically performed on an outpatient basis.
- The review synthesizes current literature on patient selection, procedural execution, and management of complications.
Main Results:
- Endovascular therapy is a safe and effective treatment for PAVMs.
- The procedure is associated with minimal morbidity and no mortality.
- Successful occlusion of feeding arteries leads to resolution of the right-to-left shunt and associated symptoms.
Conclusions:
- Endovascular therapy is the standard of care for symptomatic PAVMs, particularly in HHT patients.
- Careful patient selection and procedural technique are crucial for optimal outcomes.
- This approach effectively mitigates the risks of hypoxemia and paradoxical embolization.
More Related Videos
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
07:09Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Gene Therapy
Group Therapy
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...